Qualigen Therapeutics Share Price Today
(NASDAQ: QLGN)

Name: Qualigen Therapeutics Share Price Today (NASDAQ: QLGN) - Qualigen Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Qualigen Therapeutics share price is $3.1 & ₹269.60 as on 6 Mar 2025, 2.30 'hrs' IST

$3.1

Market is closed - opens 8 PM, 06 Mar 2025

View live Qualigen Therapeutics share price in Dollar and Rupees. Guide to invest in Qualigen Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Qualigen Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Qualigen Therapeutics share price movements

Today's Low: $3.09
Today's High: $3.18
$3.10
0.16%
Downside
Day's Volatility :2.52%
Upside
2.36%
52 Weeks Low: $2.96
52 Weeks High: $29.44
$3.10
4.52%
Downside
52 Weeks Volatility :89.94%
Upside
89.47%

Qualigen Therapeutics (QLGN) Returns

Period	Qualigen Therapeutics Inc	Index (Russel 2000)
3 Months	-31.57%	0.0%
6 Months	-62.2%	0.0%
1 Year	-84.88%	0.0%
3 Years	-98.93%	-11.6%

Qualigen Therapeutics (QLGN) Key Statistics

in dollars & INR

Previous Close	$3.1
Open	$3.1001
Today's High	$3.175
Today's Low	$3.0949
Market Capitalization	$2.3M
Today's Volume	$330.0
52 Week High	$29.435
52 Week Low	$2.96
Revenue TTM	$5.0M
EBITDA	$-6.9M
Earnings Per Share (EPS)	$3635.0
PE Ratio	0.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-841.66%

How to invest in Qualigen Therapeutics Stock (QLGN) from India?

It is very easy for Indian residents to invest directly in Qualigen Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Qualigen Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Qualigen Therapeutics or QLGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Qualigen Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Qualigen Therapeutics shares which would translate to 0.281 fractional shares of Qualigen Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Qualigen Therapeutics, in just a few clicks!

Returns in Qualigen Therapeutics (QLGN) for Indian investors in Rupees

The Qualigen Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Qualigen Therapeutics investment value today

Current value as on today

₹20,085

Returns

₹79,915

(-79.92%)

Returns from Qualigen Therapeutics Stock

₹84,878 (-84.88%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Qualigen Therapeutics (QLGN)

-36%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Qualigen Therapeutics Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Qualigen Therapeutics

Morgan Stanley - Brokerage Accounts
1.11%
Tower Research Capital LLC
0.19%
BlackRock Inc
0.07%
UBS Group AG
0.07%

Analyst Recommendation on Qualigen Therapeutics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Qualigen Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Qualigen Therapeutics Stock (QLGN)

What analysts predicted

Upside of 61.29%

Target:

$5.00

Current:

$3.10

Insights on Qualigen Therapeutics Stock (Ticker Symbol: QLGN)

Price Movement
In the last 6 months, QLGN stock has moved down by -62.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 1.38M → 7.94M (in $), with an average increase of 47.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.57M → -1.79M (in $), with an average decrease of 13.8% per quarter
QLGN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 147.2%
QLGN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.7%
Price to Sales
ForQLGN every $1 of sales, investors are willing to pay $3.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Qualigen Therapeutics Technicals Summary

Sell

Neutral

Buy

Qualigen Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Qualigen Therapeutics (QLGN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Qualigen Therapeutics Inc	-11.43%	-62.2%	-84.88%	-98.93%	-99.92%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Qualigen Therapeutics Inc	0.0	0.0	NA	0.0	-8.42	-1.26	NA	-3.9
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Qualigen Therapeutics Inc	Buy	$2.3M	-99.92%	0.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Qualigen Therapeutics

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Organization	Qualigen Therapeutics
Employees	4
CEO	Mr. Kevin A. Richardson II
Industry	Health Technology

Management People of Qualigen Therapeutics

Name	Title
Mr. Michael S. Poirier	Chief Operating Officer
Mr. Kevin A. Richardson II	Interim CEO, Interim CFO & Chairman of the Board
Mr. Robert W. Campbell Becher	President & Director
Mr. Christopher L. Lotz	VP of Finance & Corporate Secretary

Important FAQs about investing in QLGN Stock from India :

What is Qualigen Therapeutics share price today?

Qualigen Therapeutics share price today stands at $3.10, Open: $3.10 ; Previous Close: $3.10 ; High: $3.18 ; Low: $3.09 ; 52 Week High: $29.44 ; 52 Week Low: $2.96.

The stock opens at $3.10, after a previous close of $3.10. The stock reached a daily high of $3.18 and a low of $3.09, with a 52-week high of $29.44 and a 52-week low of $2.96.

Can Indians buy Qualigen Therapeutics shares?

Yes, Indians can invest in the Qualigen Therapeutics (QLGN) from India.

With INDmoney, you can buy Qualigen Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Qualigen Therapeutics at zero transaction cost.

How can I buy Qualigen Therapeutics shares from India?

It is very easy to buy Qualigen Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Qualigen Therapeutics (QLGN) be purchased?

Yes, you can buy fractional shares of Qualigen Therapeutics with INDmoney app.

What are the documents required to start investing in Qualigen Therapeutics stocks?

To start investing in Qualigen Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.